Endocrinology, Vol 134, 253-257, Copyright © 1994 by Endocrine Society

ARTICLES

Effects of nephrectomy and adrenalectomy on the renin-angiotensin system of transgenic rats TGR(mRen2)27

Y Tokita, R Franco-Saenz, PJ Mulrow and D Ganten
Department of Medicine, Medical College of Ohio, Toledo 43699.

The transgenic rat TGR(mRen2) develops severe hypertension with high renin activity in the adrenal and low renin activity in the kidney. To clarify the role of the adrenal gland as a source of circulating renin in TGR rats, we investigated the effects of nephrectomy (NEPEX) and adrenalectomy (ADX) on the adrenal and plasma renin-angiotensin system. TGR rats had a high basal plasma renin concentration (PRC; 18.2 +/- 1.0 ng angiotensin-I (AngI)/ml.h) compared with Harlan Sprague-Dawley (SD) rats (7.4 +/- 0.5 ng AngI/ml.h; P < 0.01) and SD rats of the Hannover strain from which the TGR rat was derived (5.3 +/- 0.6 ng AngI/ml.h, P < 0.01); TGR rats also had high adrenal renin (83.3 +/- 8.9) compared with Harlan SD rats (5.5 +/- 0.7; P < 0.01) and Hanover SD rats (6.1 +/- 0.6 ng AngI/ml.h). NEPEX markedly increased PRC (82.4 +/- 18.8 ng AngI/ml.h, P < 0.01) and adrenal renin levels (386.3 +/- 43.9 ng AngI/adrenal.h; P < 0.01) in TGR rats. ADX significantly lowered control levels of PRC and plasma AngII in the TGR rats (19.0 +/- 1.2 to 7.7 +/- 1.2 ng AngI/ml.h and 33.5 +/- 5.6 to 12.8 +/- 2.1 pg/ml, respectively) and suppressed the increases in PRC (119.4 +/- 20.2 to 61.8 +/- 4.0 ng AngI/ml.h) and plasma AngII (95.8 +/- 9.8 to 55.1 +/- 4.3 pg/ml; P < 0.01) caused by NEPEX in TGR rats. However, the levels of PRC and plasma AngII remained high after NEPEX/ADX in TGR rats. Our results suggest that the adrenal gland is one of the main sources of circulating renin in the TGR rat, but other extrarenal sources of plasma renin also exist in these animals.

This article has been cited by other articles:

				P. Rong, D. J. Campbell, and S. L. Skinner Hypertension in the (mRen-2)27 Rat Is Not Explained by Enhanced Kinetics of Transgenic Ren-2 Renin Hypertension, October 1, 2003; 42(4): 523 - 527. [Abstract] [Full Text] [PDF]

				P. Rong, J. L. Wilkinson-Berka, and S. L. Skinner Potassium control of extrarenal renin secretion in transgenic (mRen-2)27 and normal rats Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E631 - E638. [Abstract] [Full Text] [PDF]

				P. Rong, J. L. Wilkinson-Berka, and S. L. Skinner Renin in thymus, gut, hindlimb, and adrenal of (mRen-2)27 and normal rats: secretion and content studies Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E639 - E646. [Abstract] [Full Text] [PDF]

				Y. Yan, L. Hu, R. Chen, J. E. Sealey, J. H. Laragh, and D. F. Catanzaro Appropriate Regulation of Human Renin Gene Expression and Secretion in 45-kb Human Renin Transgenic Mice Hypertension, August 1, 1998; 32(2): 205 - 214. [Abstract] [Full Text] [PDF]

				M. Ehrhart-Bornstein, J. P. Hinson, S. R. Bornstein, W. A. Scherbaum, and G. P. Vinson Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis Endocr. Rev., April 1, 1998; 19(2): 101 - 143. [Abstract] [Full Text]

				M. Marttila, O. Vuolteenaho, D. Ganten, K. Nakao, and H. Ruskoaho Synthesis and Secretion of Natriuretic Peptides in the Hypertensive TGR(mREN-2)27 Transgenic Rat Hypertension, December 1, 1996; 28(6): 995 - 1004. [Abstract] [Full Text]

				C. Mercure, I. Jutras, R. Day, N. G. Seidah, and T. L. Reudelhuber Prohormone Convertase PC5 Is a Candidate Processing Enzyme for Prorenin in the Human Adrenal Cortex Hypertension, November 1, 1996; 28(5): 840 - 846. [Abstract] [Full Text]

				M. W. Thompson, S. B. Smith, and C. D. Sigmund Regulation of Human Renin mRNA Expression and Protein Release in Transgenic Mice Hypertension, August 1, 1996; 28(2): 290 - 296. [Abstract] [Full Text]

				M. F. Callahan, P. Li, C. M. Ferrario, D. Ganten, and M. Morris Salt-Sensitive Hypertension in (mREN-2)27 Transgenic Rats Hypertension, March 1, 1996; 27(3): 573 - 577. [Abstract] [Full Text]

				A. Moriguchi, E. A. Tallant, K. Matsumura, T. M. Reilly, H. Walton, D. Ganten, and C. M. Ferrario Opposing Actions of Angiotensin-(1-7) and Angiotensin II in the Brain of Transgenic Hypertensive Rats Hypertension, June 1, 1995; 25(6): 1260 - 1265. [Abstract] [Full Text]

				D. J. Campbell, P. Rong, A. Kladis, B. Rees, D. Ganten, and S. L. Skinner Angiotensin and Bradykinin Peptides in the TGR(mRen-2)27 Rat Hypertension, May 1, 1995; 25(5): 1014 - 1020. [Abstract] [Full Text]